Clin2
NCT07448844Likely a fitRecruiting

Comparing vitamin D3 and acyclovir shots for skin warts

Viral WartPlantar WartCommon Warts (Verruca Vulgaris)Common WartFlat WartWarts of FootWarts HandWart

Part of Infections, Skin clinical trials.

This trial tests two injected treatments (vitamin D3 or acyclovir) for common skin warts. The goal is to see which one works better for warts that are new or have not gone away with other treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
40 people
Ages
12 years and older
Study type
Interventional

Who can take part

  • Must be 12 years or older
  • Has one or more skin warts (common, on the bottom of foot, flat, or around nails)
  • Not pregnant or breastfeeding
  • No weak immune system
  • Not allergic to vitamin D3 or acyclovir
  • Has not used any wart cream, freezing, or other wart treatment in the last 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07543926Not yet recruiting
Vitamin D injection for common warts

This study tests a new way to treat common warts by injecting vitamin D directly into the wart. It may help your immune system clear the warts with minimal side effects.

Sohag
NCT07830979Not yet recruiting· Phase 3
Comparing two topical treatments for plantar warts

This trial compares two topical treatments for warts on the soles of the feet. It tests whether a 40% hydrogen peroxide solution works better than 40% salicylic acid, which is a common wart treatment.

NCT06749665Not yet recruiting
Wart treatment with sclerotherapy and candida antigen

This study tests two treatments for common warts: sclerotherapy (injecting a solution into the wart to cut off its blood supply) and candida antigen (a yeast extract that boosts the immune system to fight the wart). It aims to see if these treatments are safe and effective.

Sohag
NCT03977753Recruiting· Phase 4
Study medicine to treat common, plantar, or flat warts

This trial tests two versions of an at-home medicine to see how well they clear warts. Participants are randomly assigned to the study medicine or a placebo (inactive treatment) so researchers can compare results fairly.

Bouge
NCT07246590Recruiting· Phase 3
Cantharidin treatment for common warts in children and adults

This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.

Saint Augustine, Florida
NCT07637734Recruiting· Phase 3
Cantharidin treatment for common warts

This trial tests a medicated liquid called cantharidin for treating common warts on the body (not on the face, soles, or private areas). The liquid is painted on by a doctor and later removed, and the goal is to see if it clears warts safely.

San Diego, California

Hear when a new Common Warts (Verruca Vulgaris) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.